Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate ²¹²Pb-NNV003

• Astri Fjelde Maaland ,

  Contributed equally to this work with: Astri Fjelde Maaland, Amal Saidi

  Roles Conceptualization, Formal analysis, Methodology, Resources, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: astri.maaland@gmail.com

  Affiliations Nordic Nanovector ASA, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  http://orcid.org/0000-0002-5282-6571

  ⨯
• Amal Saidi ,

  Contributed equally to this work with: Astri Fjelde Maaland, Amal Saidi

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing – review & editing

  Affiliation Orano Med SAS, Courbevoie, France

  ⨯
• Julien Torgue,

  Roles Conceptualization, Funding acquisition, Methodology, Resources, Supervision, Writing – review & editing

  Affiliation Orano Med LLC, Plano, Texas, United States of America

  ⨯
• Helen Heyerdahl,

  Roles Conceptualization, Methodology, Resources, Supervision, Writing – review & editing

  Affiliation Nordic Nanovector ASA, Oslo, Norway

  ⨯
• Tania A. Rozgaja Stallons,

  Roles Methodology, Resources

  Affiliation Orano Med LLC, Plano, Texas, United States of America

  ⨯
• Arne Kolstad,

  Roles Conceptualization, Methodology, Supervision, Writing – review & editing

  Affiliations Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway, KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  ⨯
• Jostein Dahle

  Roles Conceptualization, Funding acquisition, Methodology, Resources, Supervision, Writing – review & editing

  Affiliation Nordic Nanovector ASA, Oslo, Norway

  ⨯